Annji Pharmaceutical Co (ROCO:7754) FCF Margin %: -37,154.89% (As of Dec. 2025)


ROCO:7754 Annji Pharmaceutical Co Ltd ROCO:7754
9 GF Score
Price NT$58.70
! 3 Warning Signs
View Full Analysis

What is Annji Pharmaceutical Co FCF Margin %?

Annji Pharmaceutical Co ROCO:7754 -0.68% 9 FCF Margin % is -37,154.89% as of Dec. 2025. GuruFocus rates ROCO:7754 with a GF Score™ of 9/100. The stock has 3 warning signs investors should review. Among 957 Biotechnology companies, Annji Pharmaceutical Co ranks worse than 89.55% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Annji Pharmaceutical Co's Free Cash Flow for the six months ended in Dec. 2025 was NT$-155.68 Mil. Annji Pharmaceutical Co's Revenue for the six months ended in Dec. 2025 was NT$0.42 Mil. Therefore, Annji Pharmaceutical Co's FCF Margin % for the quarter that ended in Dec. 2025 was -37,154.89%.

As of today, Annji Pharmaceutical Co's current FCF Yield % is -5.97%.

The historical rank and industry rank for Annji Pharmaceutical Co's FCF Margin % or its related term are showing as below:

ROCO:7754' s FCF Margin % Range Over the Past 10 Years
Min: -11777   Med: -4687.76   Max: -55.44
Current: -4687.76


During the past 5 years, the highest FCF Margin % of Annji Pharmaceutical Co was -55.44%. The lowest was -11777.00%. And the median was -4687.76%.

ROCO:7754's FCF Margin % is ranked worse than
89.55% of 957 companies
in the Biotechnology industry
Industry Median: -84.65 vs ROCO:7754: -4687.76


Annji Pharmaceutical Co FCF Margin % Related Terms


Annji Pharmaceutical Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Annji Pharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annji Pharmaceutical Co FCF Margin % Chart

Annji Pharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
-10,044.32 -11,777.00 -55.44 -203.77 -4,687.76

Annji Pharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial -115.24 -125.06 -579.08 -2,780.61 -37,154.89

ROCO:7754 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Annji Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Annji Pharmaceutical Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annji Pharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Annji Pharmaceutical Co's FCF Margin % falls into.


ROCO:7754
9GF Score
Annji Pharmaceutical Co Ltd ROCO:7754
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annji Pharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Annji Pharmaceutical Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-354.02/7.552
=-4,687.76 %

Annji Pharmaceutical Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-155.679/0.419
=-37,154.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -37,154.89% mean?
Annji Pharmaceutical Co (ROCO:7754) has a FCF Margin % of -37,154.89% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Annji Pharmaceutical Co and its competitors. According to the industry distribution chart, Annji Pharmaceutical Co ranks #857 out of 957 companies in the Biotechnology industry, placing it in the top 89.6%.
Is Annji Pharmaceutical Co's FCF Margin % too high?
Annji Pharmaceutical Co's current FCF Margin % is -37,154.89%. Based on the distribution chart, Annji Pharmaceutical Co ranks #857 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Annji Pharmaceutical Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Annji Pharmaceutical Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Annji Pharmaceutical Co ranks #857 out of 957 companies for FCF Margin %. This places Annji Pharmaceutical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Annji Pharmaceutical Co and its competitors. Annji Pharmaceutical Co's current FCF Margin % is -37,154.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annji Pharmaceutical Co stock overvalued right now?
Annji Pharmaceutical Co (ROCO:7754) has a current FCF Margin % of -37,154.89%. The current FCF Margin % is -37,154.89%. Annji Pharmaceutical Co's overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Annji Pharmaceutical Co (ROCO:7754), the current FCF Margin % is -37,154.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annji Pharmaceutical Co Business Description

Address Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.
9GF Score

Get the complete analysis for ROCO:7754

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$58.70
Price